PLK1 as a cooperating partner for BCL2-mediated antiapoptotic program in leukemia

The deregulation of BCL2 family proteins plays a crucial role in leukemia development. Therefore, pharmacological inhibition of this family of proteins is becoming a prevalent treatment method. However, due to the emergence of primary and acquired resistance, efficacy is compromised in clinical or p...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Kinjal, Nasimian, Ahmad, Ahmed, Mehreen, Al Ashiri, Lina, Denison, Linn, Sime, Wondossen, Bendak, Katerina, Kolosenko, Iryna, Siino, Valentina, Levander, Fredrik, Palm-Apergi, Caroline, Massoumi, Ramin, Lock, Richard B., Kazi, Julhash U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10484999/
https://www.ncbi.nlm.nih.gov/pubmed/37679323
http://dx.doi.org/10.1038/s41408-023-00914-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10484999/
https://www.ncbi.nlm.nih.gov/pubmed/37679323
http://dx.doi.org/10.1038/s41408-023-00914-7

Ejemplares similares